United Health Products (UEEC) Net Income towards Common Stockholders (2010 - 2026)
United Health Products (UEEC) reported Net Income towards Common Stockholders of -$265581.0 for Q1 2026, up 82.17% year-over-year from -$145790.3 in Q1 2025, and little changed quarter-over-quarter from -$264723.0 in Q4 2025.
United Health Products (UEEC) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
United Health Products (UEEC) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$265581.0 in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$265581.0, up 82.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 64.77% YoY), and the FY2025 annual result was -$2.3 million, down 12.35% from the prior year.
- Net Income towards Common Stockholders held at -$265581.0 in Q1 2026 per UEEC's latest filing, from -$264723.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$263863.0 in Q3 2025 and troughed at -$1.5 million in Q1 2025.
- A 5-year average of -$579604.0 and a median of -$458586.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders soared 96.48% in 2022, then tumbled 244.16% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$563627.0 in 2022, then gained by 25.06% to -$422409.0 in 2023, then sank by 85.93% to -$785398.0 in 2024, then jumped by 66.29% to -$264723.0 in 2025, then decreased by 0.32% to -$265581.0 in 2026.
- Business Quant data shows UEEC's Net Income towards Common Stockholders at -$265581.0 in Q1 2026, -$264723.0 in Q4 2025, and -$263863.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | United Health Products | - | - | - | -265,581.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265,581.00 |
| Dec 31, 2025 | -264,723.00 |
| Sep 30, 2025 | -263,863.00 |
| Jun 30, 2025 | -293,456.00 |
| Mar 31, 2025 | -1.49 Mn |
| Dec 31, 2024 | -785,398.00 |
| Sep 30, 2024 | -399,516.00 |
| Jun 30, 2024 | -412,790.00 |
| Mar 31, 2024 | -432,707.00 |
| Dec 31, 2023 | -422,409.00 |
| Sep 30, 2023 | -458,586.00 |
| Jun 30, 2023 | -483,660.00 |
| Mar 31, 2023 | -1.06 Mn |
| Dec 31, 2022 | -563,627.00 |
| Sep 30, 2022 | -545,851.00 |
| Jun 30, 2022 | -755,002.00 |
| Mar 31, 2022 | -954,581.00 |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -724,416.00 |
| Jun 30, 2021 | -1.30 Mn |